MAP2K1 and Langerhans cell histiocytosis: Mutations in MAP2K1, which encodes the protein MEK1, lead to the constitutive activation of the pathway, promoting the uncontrolled proliferation of Langerhans cells—a hallmark of LCH [3, 16, 17].